Iron and infection.
Sparling
P F
PF
D002170:Canada / Q000453:epidemiology; D015984:Causality; D002614:Chelating Agents / Q000627:therapeutic use; D003676:Deferoxamine / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D015009:Yersinia Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D015008:Yersinia enterocolitica / Q000302:isolation & purification; D017086:beta-Thalassemia / Q000150:complications* / Q000382:microbiology
D002614:Chelating Agents; D003676:Deferoxamine